GlassScriptPhysician profile
Tarek Ajam
NPI 1588059356
$52,650.34
in general payments reported to CMS, 2019-2025
42 companies · $5,723 in 2025
The $5,723 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $301 · 2021: $12K · 2022: $14K · 2023: $14K · 2024: $7,016 · 2025: $5,723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $13K · Consulting Fee: $1,125 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,761.69 |
| Food and Beverage | $12,551.68 |
| Consulting Fee | $1,125.00 |
| Education | $197.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21,371.86 | 2021-2025 | Micra, Abre, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $10,965.15 | 2021-2025 | Watchman Flx, Watchman Access System, Rhythmia Mapping System |
| Abbott Laboratories | $10,298.14 | 2019-2025 | Ensite Precision, Aveir, Esprit |
| Biotronik INC. | $1,876.25 | 2022-2023 | |
| Biosense Webster, INC. | $1,683.34 | 2023-2025 | Carto 3, Qdot Micro |
| Medical Device Business Services, INC. | $1,459.25 | 2019-2023 | Carto 3 |
| Altathera Pharmaceuticals LLC | $1,125.00 | 2024 | Sotalol Hydrochloride |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $588.82 | 2019-2025 | Lifevest |
| Aop Health US, LLC | $479.10 | 2025 | Rapiblyk |
| Amgen INC. | $351.96 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $229.43 | 2023-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $224.57 | 2023-2025 | Verquvo, Capvaxive |
| Cardiofocus, INC. | $223.81 | 2022-2024 | Heartlight System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.12 | 2023-2025 | Jardiance |
| Astellas Pharma US INC | $168.99 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $157.47 | 2023-2024 | Xarelto |
| Pfizer INC. | $134.21 | 2023-2025 | |
| Novo Nordisk INC | $109.68 | 2025 | Wegovy |
| Scpharmaceuticals INC. | $103.51 | 2023-2024 | |
| Atricure, INC. | $99.19 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Bayer Healthcare Pharmaceuticals INC. | $90.34 | 2025 | |
| Chiesi USA, INC. | $81.13 | 2023-2024 | Cleviprex, Kengreal |
| Esperion Therapeutics, INC. | $76.75 | 2023-2025 | Nexletol |
| Baxter Healthcare | $59.66 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $58.07 | 2025 | Ensoetm, Cardiva Vascade Mvp Vvcs 6-12f |
| Lilly USA, LLC | $56.43 | 2025 | Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals International, Plc | $56.08 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $47.66 | 2025 | Assure Wcd |
| Glaxosmithkline, LLC. | $37.27 | 2025 | Shingrix |
| Heartflow, INC. | $33.99 | 2024 | |
| Convatec INC. | $31.88 | 2023 | |
| Lantheus Medical Imaging, INC. | $28.69 | 2023 | Definity |
| Ethicon US, LLC | $24.22 | 2025 | Stratafix, Ethicon, Dermabond Prineo |
| Imperative Care, INC | $21.36 | 2024 | Symphony Catheter |
| Novartis Pharmaceuticals Corporation | $18.19 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $17.64 | 2023 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $17.51 | 2023 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $17.45 | 2023 | Arcalyst |
| Cook Medical LLC | $15.70 | 2024 | Evolution |
| Cvrx, INC. | $15.21 | 2024 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $13.54 | 2023 | Inpefa |
| Medicomp INC | $12.72 | 2023 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Ajam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.